UNI-EN 7:Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 7 | / | 2024 | |||||||
| Date of issue: | 2024-01-31 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024 | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Due to an obvious technical error in the Notification under Art. 89t of the Law on Public Offering of Securities concerning the increase of the capital of "SOPHARMA" AD, EIK 831902088, with registered office and management address Sofia, Nadezhda district, 16, Iliensko shose street by exercising warrants from an issue with ISIN code BG9200001212 published on 26 January 2024, please read “7 133 246” as 7 133 246” everywhere in the text of the notification. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_89t_corr_2024_espi_7.pdf SFA_89t_corr_2024_espi_7.pdf | Technical error in the Notification under Art. 89t of the Law on Public Offering of Securities published on 26.01.2024 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-01-31 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 14.7 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
